Details for Patent: 5,916,595
✉ Email this page to a colleague
Summary for Patent: 5,916,595
| Title: | HMG co-reductase inhibitor |
| Abstract: | A controlled release dosage formulation is described which is based on a combination of: (a) a compressed tablet core which contains an alkyl ester of a hydroxy substituted naphthalene derivative a pharmaceutically acceptable, water swellable polymer and an osmotic agent; and (b) an outer coating layer which completely covers the osmotic core and comprises a pH sensitive coating agent and a water insoluble polymer. |
| Inventor(s): | Chen; Chih-Ming (Davie, FL), Chou; Joseph (Coral Springs, FL), Wong; David (Hollywood, FL) |
| Assignee: | Andrx Pharmaceutials, Inc. (Fort Lauderdale, FL) |
| Application Number: | 08/989,253 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 5,916,595
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,916,595
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 307572 | ⤷ Try a Trial | |||
| Australia | 1360701 | ⤷ Try a Trial | |||
| Australia | 1627599 | ⤷ Try a Trial | |||
| Australia | 2004201520 | ⤷ Try a Trial | |||
| Australia | 737962 | ⤷ Try a Trial | |||
| Australia | 768950 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
